ABBV: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/f5e22dcd-3bc5-4c83-87a5-4758414daabe/","filing_uuid":"f5e22dcd-3bc5-4c83-87a5-4758414daabe","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/f5e22dcd-3bc5-4c83-87a5-4758414daabe/print/","filing_document_content_type":"text/html","income":null,"expenses":"1160000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Daniel Bachner","dt_posted":"2026-07-20T17:03:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1399 New York Avenue NW","registrant_address_2":"Suite 600","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401049961,"url":"https://lda.gov/api/v1/registrants/401049961/","house_registrant_id":null,"name":"ABBVIE, INC.","description":"Biopharmaceutical company","address_1":"1399 New York Avenue NW","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DANIEL BACHNER","contact_telephone":"+1 202-383-9616","dt_updated":"2026-08-03T09:35:22.017305-04:00"},"client":{"id":197319,"url":"https://lda.gov/api/v1/clients/197319/","client_id":12,"name":"ABBVIE INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-02-25"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S.1040, Drug Competition Enhancement Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90411,"prefix":null,"prefix_display":null,"first_name":"DORCAS","nickname":null,"middle_name":null,"last_name":"ADEKUNLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 864, HELP Copays Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act S. 2903, Safe Step Act H.R. 5509, Safe Step Act Drug cost and pricing policy issues Patient affordability issues Issues related to the 340B program Issues related to data privacy Issues related to Hepatitis C elimination Issues related to FDA communications","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90411,"prefix":null,"prefix_display":null,"first_name":"DORCAS","nickname":null,"middle_name":null,"last_name":"ADEKUNLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Public Law 117-169 (formerly known as H.R. 5376, Inflation Reduction Act) Implementation regarding Medicare Part D drug negotiation program Policy Proposals related to Medicare Part D and patient cost-sharing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Issues related to HCV treatment","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90411,"prefix":null,"prefix_display":null,"first_name":"DORCAS","nickname":null,"middle_name":null,"last_name":"ADEKUNLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1328, Supply Chain Security and Growth Act of 2025 H.R. 1990, American Innovation and R&D Competitiveness Act of 2025 Public Law No: 119-21 (formerly known as H.R. 1, One Big Beautiful Bill Act) Implementation Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation Policy proposals relating to economic activity in Puerto Rico International tax issues, including OECD digital taxation work program","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90411,"prefix":null,"prefix_display":null,"first_name":"DORCAS","nickname":null,"middle_name":null,"last_name":"ADEKUNLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":"Research Assistant (10/2016-8/2017) for Representative Louie Gohmert; Legislative Correspondent (8/2017-3/2018), Legislative Assistant (3/2018-5/2018) for Representative Bob Goodlatte","new":true},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Issues related to antitrust and competition policy","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90411,"prefix":null,"prefix_display":null,"first_name":"DORCAS","nickname":null,"middle_name":null,"last_name":"ADEKUNLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to pharmaceutic tariffs and unfair trade practices Issues related to U.S. biotech competitiveness with China","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":90411,"prefix":null,"prefix_display":null,"first_name":"DORCAS","nickname":null,"middle_name":null,"last_name":"ADEKUNLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154604,"prefix":null,"prefix_display":null,"first_name":"GAVIN","nickname":null,"middle_name":null,"last_name":"PROFFITT","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member (6/2018-1/2020) for the House Republican Study Committee; Professional Staff member (2/2023-6/2025) for the House Committee on Energy and Commerce; Health Policy Advisor (6/2025-4/2026) for Senator Ron Johnson","new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}